Abstract
Pyrido[2,3-b]pyrazines and pyrido[2,3-b]purazines-N-oxides have been synthesized and evaluated for in vitro/in vivo antagonistic activity at the glycine site on the NMDA receptor
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have